AGIOS PHARMACEUTICALS, INC.

By person

16 insiders · 44 transactions

6.6×

Brian Goff holds 6.6 times base salary in stock. $5.62M of shares against $846.86K in salary for 2025.

Salary from the company's own proxy. The shares are what Brian Goff last reported holding, valued at $30.48, the price Common stock was last bought or sold at on the open market here, on 4 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Goff Brian

Chief Executive Officer

—

$1.69M (7) scheduled

−$1.69M

184,508

0.3090%

$5.62M

+134.2%

Gheuens Sarah

Chief Medical Officer

—

$1.63M (10) scheduled

−$1.63M

54,645

0.0915%

$1.67M

+21.0%

Jones Cecilia

Chief Financial Officer

—

$468.51K (7) scheduled

−$468.51K

54,998

0.0921%

$1.68M

+238.0%

Milanova Tsveta

Chief Commercial Officer

—

$353.31K (5) scheduled

−$353.31K

46,829

0.0784%

$1.43M

+253.9%

Burns James William

Chief Legal Officer

—

$344.39K (6) scheduled

−$344.39K

49,306

0.0826%

$1.50M

+30.8%

Washburn Theodore James Jr.

Principal Accounting Officer

—

$216.63K (4)

−$216.63K

868

0.0015%

$26.46K

−47.1%

Viswanadhan Krishnan

Chief Strategy and Operations

—

$184.97K (2) scheduled

−$184.97K

10,282

0.0172%

$313.40K

—

Scadden David

Director

—

$24.97K (3) scheduled

−$24.97K

20,419

0.0342%

$622.37K

+31.9%

FOUSE JACQUALYN A

Director

—

154,156

0.2582%

$4.70M

+9.5%

Ho Maykin

Director

—

19,848

0.0332%

$604.97K

+33.1%

Ballal Rahul D.

Director

—

15,230

0.0255%

$464.21K

+90.6%

Smith Cynthia

Director

—

15,230

0.0255%

$464.21K

+90.6%

Owen Adams Catherine

Director

—

10,865

0.0182%

$331.17K

+449.8%

CAPELLO JEFFREY D

Director

—

10,865

0.0182%

$331.17K

+449.8%

Foster-Cheek Kaye I

Director

—

10,284

0.0172%

$313.46K

+92.3%

Backstrom Jay T.

Director

—

1,447

0.0024%

$44.10K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Gheuens Sarah

1 Jul 2026

Chief Medical Officer

Sold after exercise

4,007

$37.56

$150.50K

Goff Brian

2 Apr 2026

Chief Executive Officer

Sold after exercise

6,596

$34.71

$228.95K

Goff Brian

2 Apr 2026

Chief Executive Officer

Sold after exercise

12,472

$34.71

$432.90K

Viswanadhan Krishnan

2 Apr 2026

Chief Corp Dev & Strategy

Sold after exercise

2,959

$34.71

$102.71K

Milanova Tsveta

2 Apr 2026

Chief Commercial Officer

Sold after exercise

3,262

$34.71

$113.22K

Jones Cecilia

2 Apr 2026

Chief Financial Officer

Sold after exercise

3,141

$34.71

$109.02K

Gheuens Sarah

2 Apr 2026

Chief Medical Officer

Sold after exercise

2,940

$34.71

$102.05K

Burns James William

2 Apr 2026

Chief Legal Officer

Sold after exercise

3,280

$34.71

$113.85K

Viswanadhan Krishnan

5 Mar 2026

Chief Corp Dev & Strategy

Sold after exercise

2,959

$27.80

$82.26K

Washburn Theodore James Jr.

2 Mar 2026

Principal Accounting Officer

Sold after exercise

798

$28.96

$23.11K

Washburn Theodore James Jr.

2 Mar 2026

Principal Accounting Officer

Sold after exercise

727

$28.96

$21.05K

Washburn Theodore James Jr.

2 Mar 2026

Principal Accounting Officer

Sold after exercise

698

$28.96

$20.21K

Milanova Tsveta

2 Mar 2026

Chief Commercial Officer

Sold after exercise

1,187

$28.96

$34.38K

Milanova Tsveta

2 Mar 2026

Chief Commercial Officer

Sold after exercise

1,681

$28.96

$48.68K

Jones Cecilia

2 Mar 2026

Chief Financial Officer

Sold after exercise

1,573

$28.96

$45.55K

Jones Cecilia

2 Mar 2026

Chief Financial Officer

Sold after exercise

1,187

$28.96

$34.38K

Jones Cecilia

2 Mar 2026

Chief Financial Officer

Sold after exercise

1,681

$28.96

$48.68K

Jones Cecilia

2 Mar 2026

Chief Financial Officer

Sold after exercise

594

$28.96

$17.20K

Gheuens Sarah

2 Mar 2026

Chief Medical Officer

Sold after exercise

1,187

$28.96

$34.38K

Gheuens Sarah

2 Mar 2026

Chief Medical Officer

Sold after exercise

1,681

$28.96

$48.68K

Gheuens Sarah

2 Mar 2026

Chief Medical Officer

Sold after exercise

1,187

$28.96

$34.38K

Burns James William

2 Mar 2026

Chief Legal Officer

Sold after exercise

1,163

$28.96

$33.68K

Burns James William

2 Mar 2026

Chief Legal Officer

Sold after exercise

1,187

$28.96

$34.38K

Burns James William

2 Mar 2026

Chief Legal Officer

Sold after exercise

1,681

$28.96

$48.68K

Burns James William

2 Mar 2026

Chief Legal Officer

Sold after exercise

1,187

$28.96

$34.38K

Goff Brian

2 Mar 2026

Chief Executive Officer

Sold after exercise

5,918

$28.96

$171.39K

Goff Brian

2 Mar 2026

Chief Executive Officer

Sold after exercise

8,267

$28.96

$239.41K

Goff Brian

2 Mar 2026

Chief Executive Officer

Sold after exercise

3,870

$28.96

$112.08K

Milanova Tsveta

5 Jan 2026

Chief Commercial Officer

Sold after exercise

2,872

$27.02

$77.60K

Jones Cecilia

30 Dec 2025

Chief Financial Officer

Sold after exercise

2,932

$27.09

$79.43K

Milanova Tsveta

30 Dec 2025

Chief Commercial Officer

Sold after exercise

2,932

$27.09

$79.43K

Gheuens Sarah

30 Dec 2025

Chief Medical Officer

Sold after exercise

2,932

$27.09

$79.43K

Goff Brian

30 Dec 2025

Chief Executive Officer

Sold after exercise

6,230

$27.09

$168.77K

Goff Brian

30 Dec 2025

Chief Executive Officer

Sold after exercise

12,473

$27.09

$337.89K

Burns James William

30 Dec 2025

Chief Legal Officer

Sold after exercise

2,932

$27.09

$79.43K

Scadden David

12 Nov 2025

Director

Sold after exercise

200

$43.84

$8.77K

Gheuens Sarah

11 Nov 2025

Chief Medical Officer

Sold after exercise

2,454

$43.78

$107.44K

Gheuens Sarah

30 Oct 2025

Chief Medical Officer

Sold after exercise

200

$43.81

$8.76K

Gheuens Sarah

27 Oct 2025

Chief Medical Officer

Sold after exercise

3,302

$43.92

$145.02K

Scadden David

8 Oct 2025

Director

Sold after exercise

200

$41.00

$8.20K

Scadden David

30 Sep 2025

Director

Sold after exercise

200

$40.00

$8.00K

Jones Cecilia

26 Sep 2025

Chief Financial Officer

Sold after exercise

3,651

$36.77

$134.25K

Show all 44 transactions →

AGIOS PHARMACEUTICALS, INC.

By person

Individual transactions

What was left out